Yasmin Alam

First-Line Erlotinib Followed by Second-Line Cisplatin-Gemcitabine Chemotherapy in Advanced Non–Small-Cell Lung Cancer: The TORCH Randomized Trial

Cesare Gridelli, Fortunato Ciardiello, Ciro Gallo et al. · Journal of Clinical Oncology · 2012 · 234 citations · Full text

Medicine, Oncology, Pharmacology +16

Keratin 15 Expression in Stratified Epithelia: Downregulation in Activated Keratinocytes

Ahmad Waseem, Yasmin Alam, Anand Lalli et al. · Journal of Investigative Dermatology · 1999 · 199 citations · Full text

Life Sciences, Cell Biology, Dermatology +8

Randomized Phase II Study of Gemcitabine Plus Cisplatin or Carboplatin, With or Without Cetuximab, As First-Line Therapy for Patients With Advanced or Metastatic Non–Small-Cell Lung Cancer

Charles Butts, David Bodkin, Edward L. Middleman et al. · Journal of Clinical Oncology · 2007 · 196 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase II Study of Vandetanib or Placebo in Small-Cell Lung Cancer Patients After Complete or Partial Response to Induction Chemotherapy With or Without Radiation Therapy: National Cancer Institute of Canada Clinical Trials Group Study BR.20

Andrew Arnold, Lesley Seymour, Michael Smylie et al. · Journal of Clinical Oncology · 2007 · 196 citations · Full text

Medicine, Oncology, Pharmacology +17

Prolongation of rat corneal graft survival by treatment with anti-CD4 monoclonal antibody.

W Ayliffe, Yasmin Alam, Eric B. Bell et al. · British Journal of Ophthalmology · 1992 · 90 citations · Full text

Life Sciences, Immunology, Ophthalmology +17